Cerity Partners LLC Bristol Myers Squibb CO Transaction History

Cerity Partners LLC

$37.7 Billion
Q2 2024

A detailed history of Cerity Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cerity Partners LLC holds 641,830 shares of BMY stock, worth $32.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

641,830

Previous 883,419 27.35%

Holding current value

$32.7 Million

Previous $47.9 Million 44.36%

% of portfolio

0.07%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $9.72 Million - $12.8 Million	-241,589 Reduced 27.35%	641,830 $26.7 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $24.4 Million - $27.6 Million	507,727 Added 135.14%	883,419 $47.9 Million
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $2.63 Million - $3.14 Million	54,351 Added 16.91%	375,692 $19.3 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $17 Million - $19 Million	-292,888 Reduced 47.68%	321,341 $18.7 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $4.51 Million - $5 Million	70,722 Added 13.01%	614,229 $39.3 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $4.64 Million - $5.27 Million	70,677 Added 14.95%	543,507 $37.7 Million
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $12.7 Million - $15 Million	184,763 Added 64.14%	472,830 $34 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $467 - $276,316	-3,596 Reduced 1.23%	288,067 $20.5 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $3.27 Million - $3.6 Million	45,040 Added 18.26%	291,663 $22.5 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $1.81 Million - $2.17 Million	29,495 Added 13.58%	246,623 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.14 Million - $1.32 Million	21,173 Added 10.81%	217,128 $13.5 Million
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $1.05 Million - $1.23 Million	17,766 Added 9.97%	195,955 $11.6 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $9,657 - $10,517	-156 Reduced 0.09%	178,189 $11.9 Million
Q1 2021 Aug 11, 2021	SELL	$59.34 - $66.74 $2.06 Million - $2.32 Million	-34,719 Reduced 16.3%	178,345 $11.3 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $183,657 - $206,560	-3,095 Reduced 1.43%	213,064 $13.5 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $2.77 Million - $3.14 Million	48,022 Added 28.56%	216,159 $13.4 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $4.77 Million - $5.28 Million	82,981 Added 97.45%	168,137 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.91 Million - $2.23 Million	34,792 Added 69.08%	85,156 $5.01 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $251,209 - $365,066	-5,414 Reduced 9.71%	50,364 $2.81 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $511,882 - $667,704	10,402 Added 22.92%	55,778 $3.58 Million
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $36,097 - $42,799	-844 Reduced 1.83%	45,376 $2.3 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $199,272 - $220,352	-4,466 Reduced 8.81%	46,220 $2.1 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $62,355 - $74,351	-1,382 Reduced 2.65%	50,686 $2.42 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $16,480 - $21,371	338 Added 0.65%	52,068 $2.71 Million
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $167,115 - $188,493	3,028 Added 6.22%	51,730 $3.21 Million
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $34,360 - $42,826	680 Added 1.42%	48,702 $2.7 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $398,408 - $458,648	-6,649 Reduced 12.16%	48,022 $3.04 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $141,098 - $153,833	2,354 Added 4.5%	54,671 $3.35 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $2.89 Million - $3.33 Million	52,317	52,317 $3.34 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Bristol Myers Squibb CO Transaction History